Related references
Note: Only part of the references are listed.Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia
Dragana Milojkovic et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemia
Theis H. Terwey et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Performance status, but not the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI), predicts mortality at a Canadian transplant center
R. Guilfoyle et al.
BONE MARROW TRANSPLANTATION (2009)
The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome
Esther Zipperer et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation
L. Farina et al.
LEUKEMIA (2009)
Pretreatment C-Reactive Protein Is a Predictor for Outcomes after Reduced-intensity Allogeneic Hematopoietic Cell Transplantation
Andrew S. Artz et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Failure to achieve a major cytogenetic response by 12 months defines inadequate response in patients receiving nilotinib or dasatinib as second or subsequent line therapy for chronic myeloid leukemia
Constantine S. Tam et al.
BLOOD (2008)
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation
Mohamed Sorror et al.
CANCER (2008)
Impact of comorbidity indexes on non-relapse mortality
A. Xhaard et al.
LEUKEMIA (2008)
Hematopoietic cell transplantation-specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences
Mohamed L. Sorror et al.
BLOOD (2007)
Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia
Sergio A. Giralt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels
CS Carlson et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
C-reactive protein and the risk of incident colorectal cancer
TP Erlinger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Genetic polymorphisms predicting the outcome of bone marrow transplants
AM Dickinson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants
JR Passweg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Share Paper
